Interleukin-10 promoter polymorphism in psoriasis

Journal of Investigative Dermatology

Volumn 116, Issue 6, 2001, Pages 975-978

  Asadullah, Khusru ^a   Eskdale, Joyce ^b   Wiese, Anja ^a   Gallagher, Grant ^b   Friedrich, Markus ^a   Sterry, Wolfram ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cytokines; Genetic; Interleukins; Polymorphism; Psoriasis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MICROSATELLITE DNA;

AGE; ALLELE; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; STATISTICAL ANALYSIS;

EID: 0034979546     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01350.x     Document Type: Article

References (28)

1. IL-10 is a key cytokine in psoriasis: Proof of principle by IL-10 therapy - A new therapeutic approach
2. IL-10 treatment of psoriasis - Clinical results of a Phase II trial
3. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: An association with systemic tumour necrosis factor α overexpression
4. Interleukin-10 in cutaneous disorders: Implications for its pathophysiological importante and therapeutic use
5. Cytokine gene polymorphism in human disease: On-line databases
6. Correlated increases of tumour necrosis factor-α, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - Relationships with disease severity
7. The pathogenesis of psoriasis: Immunological facts and speculations
8. New polymorphisms in the IL-10 promoter region
9. Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10
10. A polymorphic dinucleotide repeat in the human IL-10 promoter
11. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL-10 gene
12. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence
13. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus
14. Interleukin 10 secretion in relation to human locus haplotypes
15. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus
16. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions
17. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis
18. Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test
19. Cytokine (TNF, LT and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies
20. Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor
21. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus
22. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids
23. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis and Sézary syndrome, but not in psoriatic plaques
24. Treatment of psoriasis with Interleukin-10
25. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis
26. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci
27. An investigation of polymorphism in the interleukin-10 gene promoter
28. Psoriasis: A disease of abnormal keratinocyte proliferation induced by T lymphocytes